Sequenom, Inc.
Sequenom to Raise $20 Million in Registered Direct Offering Priced at a Premium to Market
Published in Law and Health Weekly, May 12th, 2007
Sequenom, Inc. (NASDAQ:SQNM) announced that it has obtained commitments from several new and existing unaffiliated institutional investors to purchase $20.0 million of its common stock. Under the terms of the transaction, Sequenom intends to sell 6,666,666 shares at $3.00 per share, representing a premium to the last sale price on April 24, 2007 of $2.99. The transaction is subject to certain customary closing conditions and is expected to close on or about April 27, 2006. The aggregate gross proceeds of the offering are expected to be approximately $20 million and aggregate net proceeds, after deducting the placement agents' fees and estimated offering expenses payable by Sequenom, are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- AARP
Calls for Rx Marketing Reform to Lower Cost of Prescription Drugs - ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Exercise of Over-Allotment by Underwriters - Allergies
Allergy & Asthma Network Mothers of Asthmatics Exposes Potentially Dangerous Asthma Medications - Altus Pharmaceuticals
Altus Pharmaceuticals Announces Pricing of Public Offering of 6,000,000 Shares of Common Stock - Altus Pharmaceuticals Inc.
Altus Pharmaceuticals Announces Closing of $88.5 Million Public Offering - American Tort Reform Association
Survey Shows Alabamans Expect Transparency, Accountability From Attorney General - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
